Pfizer's phase 3 trial of Lyrica in primary generalized tonic─ clonic seizures fails to meet primary

Pfizer Inc announced that a phase 3 study to assess the use of Lyrica (pregabalin) as adjunctive therapy for epilepsy patients 5 to 65 years of age with primary ... Lees verder

Bron:

Pharmamarketeer